Literature DB >> 27275470

An unusual case of adrenocortical carcinoma with liver metastasis that occurred at 23 years after surgery.

Damien Bergeat1, Michel Rayar1, Luc Beuzit1, Giovanni Battista Levi Sandri1, Julien Dagher1, Aude Merdrignac1, Laetitia Tanguy1, Karim Boudjema1, Laurent Sulpice1, Bernard Meunier1.   

Abstract

Adrenocortical carcinoma (ACC) is an uncommon and aggressive cancer occurring more frequently in women; local or distant recurrences occur in 80% of cases, typically within 1 year after curative resection. Liver is the preferred metastatic site. Herein, we report the case of a unique liver metastasis from ACC occurring 23 years after the curative prior tumor surgery. A 45-year-old woman was operated in 1991 for adrenocortical stage II without microvascular involvement or capsular infiltration. At that time, no adjuvant treatment was indicated. The initial surgery consisted on a left adrenalectomy with contemporaneous left nephrectomy and regional lymphadenectomy. Five years after surgery, the patient was considered cured. However, 23 years later, the patient presented an atypical right subcostal pain. A 4 cm liver ACC metastasis involving the segment 4 and initially diagnosed as a hemangioma was discovered. A curative resection of the segment 4 was performed. Final pathological examination confirmed the diagnosis of ACC metastasis with a complete R0 resection; no lymph node metastases were observed. This case is the latest metachronous ACC metastasis ever reported in literature. To date, the patient is alive with no signs of recurrence after a post-surgical follow-up of 13 months.

Entities:  

Keywords:  Adrenocortical carcinoma (ACC); liver metastasis; liver resection

Year:  2016        PMID: 27275470      PMCID: PMC4876254          DOI: 10.21037/hbsn.2016.03.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  14 in total

1.  Endoscopic adrenalectomy: the adrenals under the scope?

Authors:  M A Cuesta; H J Bonjer; J C van Mourik
Journal:  Clin Endocrinol (Oxf)       Date:  1996-03       Impact factor: 3.478

2.  Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.

Authors:  Masha Livhits; Ning Li; Michael W Yeh; Avital Harari
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

3.  Pathologic features of prognostic significance in adrenocortical carcinoma.

Authors:  L M Weiss; L J Medeiros; A L Vickery
Journal:  Am J Surg Pathol       Date:  1989-03       Impact factor: 6.394

Review 4.  Adrenocortical carcinoma: the management of metastatic disease.

Authors:  André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri
Journal:  Crit Rev Oncol Hematol       Date:  2014-06-04       Impact factor: 6.312

5.  Operative management for recurrent and metastatic adrenocortical carcinoma.

Authors:  Nicole M Datrice; Russell C Langan; R Taylor Ripley; Clinton D Kemp; Seth M Steinberg; Bradford J Wood; Steven K Libutti; Tito Fojo; David S Schrump; Itzhak Avital
Journal:  J Surg Oncol       Date:  2011-12-20       Impact factor: 3.454

6.  Transcatheter arterial chemoembolization for liver metastases in patients with adrenocortical carcinoma.

Authors:  Julien Cazejust; Thierry De Baère; Anne Auperin; Frédéric Deschamps; Lukas Hechelhammer; Mohamed Abdel-Rehim; Martin Schlumberger; Sophie Leboulleux; Eric Baudin
Journal:  J Vasc Interv Radiol       Date:  2010-10       Impact factor: 3.464

7.  Liver resection and ablation for metastatic adrenocortical carcinoma.

Authors:  R Taylor Ripley; Clinton D Kemp; Jeremy L Davis; Russell C Langan; Richard E Royal; Steven K Libutti; Seth M Steinberg; Bradford J Wood; Udai S Kammula; Tito Fojo; Itzhak Avital
Journal:  Ann Surg Oncol       Date:  2011-02-08       Impact factor: 5.344

8.  The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy.

Authors:  Julie H Song; Fakhra S Chaudhry; William W Mayo-Smith
Journal:  AJR Am J Roentgenol       Date:  2008-05       Impact factor: 3.959

Review 9.  Clinical review: Adrenocortical carcinoma: clinical update.

Authors:  Bruno Allolio; Martin Fassnacht
Journal:  J Clin Endocrinol Metab       Date:  2006-03-21       Impact factor: 5.958

10.  Hepatic metastasis from adrenocortical carcinoma fifteen years after primary resection.

Authors:  Mohammed Mawardi; Bandar Al-Judaibi; Paul Marotta
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485

View more
  3 in total

1.  Actual 10-year survivors following resection of adrenocortical carcinoma.

Authors:  Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Jason D Prescott; Tracy S Wang; Jason Glenn; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Ioannis Hatzaras; Rivfka Shenoy; Timothy M Pawlik; Jeffrey A Norton; George A Poultsides
Journal:  J Surg Oncol       Date:  2016-09-16       Impact factor: 3.454

2.  Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Authors:  Mircea-Florin Costache; Raluca-Elena Arhirii; Simona-Juliette Mogos; Corina Lupascu-Ursulescu; Cezara-Ioana Litcanu; Adi-Ionut Ciumanghel; Catalina Cucu; Cristina-Mihaela Ghiciuc; Antoniu-Octavian Petris; Nicolae Danila
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 3.  Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Authors:  Alfred King-Yin Lam
Journal:  Biomedicines       Date:  2021-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.